fda d.i.s.c.o. burst edition: fda approvals of tecentriq (atezolizumab) for unresectable or metas...
Published 6 months ago • 45 plays • Length 7:01Download video MP4
Download video MP3
Similar videos
-
4:01
fda d.i.s.c.o. burst edition: fda approval of tecentriq (atezolizumab) for adjuvant treatment fol...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of tibsovo (ivosidenib) in combination with azacitidin...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of padcev (enfortumab vedotin-ejfv) with keytruda (pem...
-
5:01
fda d.i.s.c.o. burst edition: fda approval of tafinlar (dabrafenib) in combination with mekinist ...
-
5:01
fda d.i.s.c.o. burst edition: fda approvals of tivdak (tisotumab vedotin-tftv) for recurrent or m...
-
2:31
fda d.i.s.c.o. burst edition: fda approval of zynyz (retifanlimab-dlwr) for metastatic or recurre...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of tafinlar (dabrafenib) with mekinist (trametinib) fo...
-
7:01
fda d.i.s.c.o. burst edition: fda approvals of tabrecta (capmatinib) for metastatic non-small cel...
-
5:07
a dysregulated nervous system: what is it? and what to do about it?
-
9:25
dr david spigel interview tecentriq
-
4:18
tecentriq branded moa video
-
3:31
fda d.i.s.c.o. burst edition: fda approval of tibsovo (ivosidenib) for patients with relapsed or ...
-
6:00
fda d.i.s.c.o. burst edition: fda approvals of jemperli (dostarlimab-gxly) for patients with mism...
-
5:01
fda d.i.s.c.o. burst edition: fda approvals of augtyro (repotrectinib) for ntrk gene fusion-posit...
-
4:31
fda d.i.s.c.o.: burst edition: fda approval of pluvicto (lutetium lu 177 vipivotide tetraxetan) f...
-
4:01
fda d.i.s.c.o. burst edition: fda approval yescarta (axicabtagene ciloleucel) for adult patients ...
-
4:01
fda d.i.s.c.o. burst edition: fda approves a new dosing regimen for asparaginase erwinia chrysant...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of vidaza (azacitidine) for pediatric patients with ne...
-
6:01
fda d.i.s.c.o. burst edition: fda approvals of imbruvica (ibrutinib) for pediatric patients with ...
-
8:01
fda d.i.s.c.o.: fda approval of cablivi for acquired thrombotic thrombocytopenic purpura
-
7:31
fda d.i.s.c.o.: fda approval of larotrectinib for advanced malignancies with ntrk gene fusion